Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for neuropathic pain and spasticity after spinal cord injury
2012-005328-14Phase 3Terminated
- Sponsor
- Spinal Cord Injury Centre of Western Denmark
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cannabidiol in Neuralgia and Muscle spasm (2 arms), sponsored by Spinal Cord Injury Centre of Western Denmark. Started Apr 2013; status: terminated.
02
Drugs
cannabidiol
03
Conditions
NeuralgiaMuscle spasm
Beyond the preview
Go deeper on 2012-005328-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005328-14.